Curis | CRIS - Loan Capital


Curis reported $29.43M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Amgen USD 51.89B 1.88B Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Bayer EUR 31.83B 877M Dec/2025
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Eli Lilly USD 39.37B 1.5B Mar/2026
Gilead Sciences USD 22.13B 6M Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Incyte USD 29.41M 785K Mar/2026
Merck USD 46.67B 77M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Takeda JPY 4.27T 81.29B Dec/2025
TG Therapeutics USD 245.64M 305K Dec/2025
Verastem USD 81.33M 31.01M Dec/2025
Xoma USD 94.38M 7.82M Sep/2025